DOSSIER · 13F Holders · Q1 2026Healthcare · In Vitro & In Vivo Diagnostic SubstancesHigh-convictionMulti-bagger
NTLA
INTELLIA THERAPEUTICS INC
328 institutions still hold INTELLIA THERAPEUTICS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 45826J105·In Vitro & In Vivo Diagnostic Substances·328 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
328 institutions reported NTLA in Q1 2026. ARK Investment Management LLC leads at 17.4% of the visible book. -2 net institutions QoQ — distribution reading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 17
308 more holders available. Log in →